0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

The Use of Statins in Conjunction With Protease Inhibitors and in Renal Insufficiency—Reply

Christie M. Ballantyne, MD
Arch Intern Med. 2003;163(13):1616. doi:10.1001/archinte.163.13.1615-a.
Text Size: A A A
Published online

Extract

In reply

We thank Drs Mikhail and Cope for pointing out the importance of the potential drug interactions between statins and protease inhibitors, particularly ritonavir, which is a potent inhibitor of cytochrome (CY) P3A4. However, in addition to the 2 cases of rhabdomyolysis due to probable interaction with simvastatin and ritonavir that were referenced, an additional case of rhabdomyolysis due to atorvastatin and delavirdine has been reported in an individual receiving 20 mg of atorvastatin.1 The most common clinical abnormality associated with ritonavir use is a marked elevation in triglyceride levels that cannot be controlled by statin monotherapy, and clearly this patient population merits further investigation. A recent review of the new lopinavir-ritonavir formulation notes that there were no clinically significant interactions with pravastatin, which is not metabolized through the CYP3A4 system, nor were there expected to be interactions with fluvastatin, which also is not metabolized through the CYP3A4 system.2 In regard to the recommendation in the article not to prescribe high-dose statin therapy for patients with renal insufficiency, we disagree with Drs Mikhail and Cope that this recommendation should not apply to atorvastatin. Primary care physicians were cautioned not to use maximal-dose statins in patients with renal insufficiency because rhabdomyolysis in this patient population is much more likely to result in acute renal failure compared with individuals with normal renal function. Currently, there are no published prospective, long-term studies that have used 80 mg of atorvastatin in patients with renal insufficiency, with the only 2 published trials limiting the dose to 40 mg.3,4

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

* * SCHEDULED MAINTENANCE * *

Our websites may be periodically unavailable between midnight and 04:00 ET Thursday, July 10th, for regularly scheduled maintenance.

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 6

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs
JAMAevidence.com

Users' Guides to the Medical Literature
Clinical Scenario

Users' Guides to the Medical Literature
Statin Dosing and LDL Levels

brightcove.createExperiences();